Form 8-K - Current report:
SEC Accession No. 0001193125-26-197857
Filing Date
2026-04-30
Accepted
2026-04-30 17:19:05
Documents
11
Period of Report
2026-04-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axsm-20260430.htm   iXBRL 8-K 46832
2 EX-99.1 axsm-ex99_1.htm EX-99.1 108502
3 GRAPHIC img36028404_0.gif GRAPHIC 10743
  Complete submission text file 0001193125-26-197857.txt   288697

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT axsm-20260430.xsd EX-101.SCH 23858
14 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20260430_htm.xml XML 4543
Mailing Address ONE WORLD TRADE CENTER, 29TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 29TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 26927272
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)